Clinical Trials Browser

Unknown × Interventional × MART-1 Antigen × Clear all

NCT00010309 2014-01-06

Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma

Phase 1/2 Unknown

Melanoma

NCT00037037 2013-12-18

Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma

Phase 1 Unknown

Melanoma